## Flora Growth Expands into Australian Medical Cannabis Market with Canopy Growth Partnership
Flora Growth Corp. (FLGC) is making waves in the global medical cannabis market, announcing a strategic distribution agreement with industry giant Canopy Growth Corp. (CGC). This exciting partnership will see Flora bring Canopy’s renowned Storz & Bickel medical vaporizers to the burgeoning Australian market.
The distribution will be handled by Flora’s subsidiary, Australian Vaporizers, who are poised to make a significant impact on the country’s medical cannabis landscape. “Canopy Growth is a market leader with a $400 million market capitalization. We are very much interested in partnering with Canopy Growth to bring their highly regarded Storz vaporizers to the Australian market,” stated Clifford Starke, chairman and chief executive officer of Flora Growth. “With Australian Vaporizers at the forefront of this initiative, we are confident that our distribution of Canopy’s Storz products will further enhance the standard of care for medical cannabis patients in Australia.”
This strategic move comes at a time of significant growth for the Australian medical cannabis market. According to Grand View Research, the market size was estimated at $94 million in 2024 and is projected to grow at a CAGR of 33.6% from 2024 to 2030. This partnership positions Flora to capitalize on this growing demand, providing healthcare professionals and clinics across the country with access to high-quality medical cannabis consumption solutions.
Canopy Growth’s Storz vaporizers are meticulously designed to meet the specific needs of the medical cannabis community. Patient safety is a top priority, and the vaporizers offer some of the most innovative features on the market. Each device is built with precision for optimal dosing and efficiency, ensuring users receive a consistent and controlled experience.
This latest venture builds on Flora Growth’s recent expansion efforts across Europe. The company recently signed an exclusive distribution deal with Canapuff, a Czech Republic-based provider of cannabinoid consumer products, to introduce its Vessel brand of cannabis accessories into the Central European market. Additionally, Flora has entered into a supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market. This collaboration will introduce two strains, Chemmy Jones and Northern Lights, to the German market, further solidifying Flora’s presence in the region.
These strategic moves highlight Flora Growth’s commitment to driving innovation and accessibility in the medical cannabis sector. As the company continues to expand its global footprint, it is well-positioned to become a leading force in this rapidly growing market.